169 related articles for article (PubMed ID: 24894324)
1. Monitoring of therapy in atopic dermatitis--observations with the use of high-frequency ultrasonography.
Polańska A; Silny W; Jenerowicz D; Knioła K; Molińska-Glura M; Dańczak-Pazdrowska A
Skin Res Technol; 2015 Feb; 21(1):35-40. PubMed ID: 24894324
[TBL] [Abstract][Full Text] [Related]
2. Topical tacrolimus vs medium-dose ultraviolet A1 phototherapy in the treatment of atopic dermatitis - a preliminary study in relation to parameters of the epidermal barrier function and high-frequency ultrasonography.
Osmola-Mańkowska A; Polańska A; Silny W; Żaba R; Adamski Z; Dańczak-Pazdrowska A
Eur Rev Med Pharmacol Sci; 2014; 18(24):3927-34. PubMed ID: 25555886
[TBL] [Abstract][Full Text] [Related]
3. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
4. Seemingly healthy skin in atopic dermatitis: observations with the use of high-frequency ultrasonography, preliminary study.
Dańczak-Pazdrowska A; Polańska A; Silny W; Sadowska A; Osmola-Mańkowska A; Czarnecka-Operacz M; Zaba R; Jenerowicz D
Skin Res Technol; 2012 May; 18(2):162-7. PubMed ID: 21535189
[TBL] [Abstract][Full Text] [Related]
5. Stratification of atopic dermatitis patients by patterns of response to proactive therapy with topical tacrolimus: low serum IgE levels and inadequately controlled disease activity at the start of treatment predict its failure.
Kasai H; Kawasaki H; Fukushima-Nomura A; Yasuda-Sekiguchi F; Amagai M; Ebihara T; Tanese K
Ann Med; 2021 Dec; 53(1):2205-2214. PubMed ID: 34797182
[TBL] [Abstract][Full Text] [Related]
6. Open-label, pilot study examining sequential therapy with oral tacrolimus and topical tacrolimus for severe atopic dermatitis.
Keaney TC; Bhutani T; Sivanesan P; Bandow GD; Weinstein SB; Cheung LC; Malick F; Koo J
J Am Acad Dermatol; 2012 Oct; 67(4):636-41. PubMed ID: 22221776
[TBL] [Abstract][Full Text] [Related]
7. Atopic dermatitis in children in the United States, 1997-2004: visit trends, patient and provider characteristics, and prescribing patterns.
Horii KA; Simon SD; Liu DY; Sharma V
Pediatrics; 2007 Sep; 120(3):e527-34. PubMed ID: 17766497
[TBL] [Abstract][Full Text] [Related]
8. Topical calcineurin inhibitors in the treatment of atopic dermatitis - an update on safety issues.
Czarnecka-Operacz M; Jenerowicz D
J Dtsch Dermatol Ges; 2012 Mar; 10(3):167-72. PubMed ID: 21974750
[TBL] [Abstract][Full Text] [Related]
9. No evidence of increased cancer incidence in children using topical tacrolimus for atopic dermatitis.
Paller AS; Fölster-Holst R; Chen SC; Diepgen TL; Elmets C; Margolis DJ; Pollock BH
J Am Acad Dermatol; 2020 Aug; 83(2):375-381. PubMed ID: 32246968
[TBL] [Abstract][Full Text] [Related]
10. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
11. [Post-marketing surveillance on treatment of 5,665 patients with atopic dermatitis using the calcineurin inhibitor pimecrolimus: positive effects on major symptoms of atopic dermatitis and on quality of life].
Sunderkötter C; Weiss JM; Bextermöller R; Löffler H; Schneider D
J Dtsch Dermatol Ges; 2006 Apr; 4(4):301-6. PubMed ID: 16638059
[TBL] [Abstract][Full Text] [Related]
12. Comparison between high-frequency ultrasonography (Dermascan C, version 3) and histopathology in atopic dermatitis.
Polańska A; Dańczak-Pazdrowska A; Silny W; Woźniak A; Maksin K; Jenerowicz D; Janicka-Jedyńska M
Skin Res Technol; 2013 Nov; 19(4):432-7. PubMed ID: 23521510
[TBL] [Abstract][Full Text] [Related]
13. Ultrasonography patterns of atopic dermatitis in children.
Sorokina E; Mikailova D; Krakhaleva J; Krinitsyna J; Yakubovich A; Sergeeva I
Skin Res Technol; 2020 Jul; 26(4):482-488. PubMed ID: 31930616
[TBL] [Abstract][Full Text] [Related]
14. The role of topical calcineurin inhibitors in atopic dermatitis.
Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
[TBL] [Abstract][Full Text] [Related]
15. A single-center open-label long-term comparison of tacrolimus ointment and topical corticosteroids for treatment of atopic dermatitis.
Neumann E; Amtage D; Bruckner-Tuderman L; Mockenhaupt M
J Dtsch Dermatol Ges; 2008 Jul; 6(7):548-53. PubMed ID: 18248495
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis.
Bieber T; Vick K; Fölster-Holst R; Belloni-Fortina A; Städtler G; Worm M; Arcangeli F
Allergy; 2007 Feb; 62(2):184-9. PubMed ID: 17298428
[TBL] [Abstract][Full Text] [Related]
18. Twice-daily versus once-daily applications of pimecrolimus cream 1% for the prevention of disease relapse in pediatric patients with atopic dermatitis.
Ruer-Mulard M; Aberer W; Gunstone A; Kekki OM; López Estebaranz JL; Vertruyen A; Guettner A; Hultsch T
Pediatr Dermatol; 2009; 26(5):551-8. PubMed ID: 19840309
[TBL] [Abstract][Full Text] [Related]
19. Potential of high-frequency ultrasonography in the management of atopic dermatitis.
Sabău M; Boca AN; Ilies RF; Tătaru A
Exp Ther Med; 2019 Feb; 17(2):1073-1077. PubMed ID: 30679976
[TBL] [Abstract][Full Text] [Related]
20. First experience with extended release tacrolimus in the treatment of adult patients with severe, difficult to treat atopic dermatitis: Clinical efficacy, safety and dose finding.
van der Schaft J; van Schaik RH; van Zuilen AD; Hijnen DJ; Berg MT; van den Broek MP; Bruijnzeel-Koomen CA; de Bruin-Weller MS
J Dermatol Sci; 2016 Jan; 81(1):66-8. PubMed ID: 26547110
[No Abstract] [Full Text] [Related]
[Next] [New Search]
